Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

What Nvidia’s cross into $4 trillion territory means, Facebook lawsuit gets a quick settlement, Perplexity’s new AI web browser.

Chicago, IL – July 17, 2025– Today, Zacks Investment Ideas feature highlights Alphabet GOOGL, Meta Platforms META, Tesla TSLA ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In a recent study by the AI security firm PalisadeAI, a new, unnerving behavior was revealed: several advanced artificial intelligence models successfully bypassed shutdown instructions, with one ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.